Exploring the dual character of metformin in Alzheimer's disease

P Ning, A Luo, X Mu, Y Xu, T Li - Neuropharmacology, 2022 - Elsevier
Alzheimer's disease (AD) is the most common neurodegenerative disease, which results in
dementia typically in the elderly. The disease is mainly characterized by the deposition of …

Posttranscriptional regulation of Nrf2 through miRNAs and their role in Alzheimer's disease

RK Kaundal, AK Datusalia, SS Sharma - Pharmacological research, 2022 - Elsevier
The nuclear factor erythroid-derived 2-related factor 2 (NFE2L2/Nrf2) is a pivotal facilitator of
cytoprotective responses against the oxidative/electrophilic insults. Upon activation, Nrf2 …

TRIM18 is a critical regulator of viral myocarditis and organ inflammation

M Fang, A Zhang, Y Du, W Lu, J Wang… - Journal of biomedical …, 2022 - Springer
Background Infections by viruses including severe acute respiratory syndrome coronavirus 2
could cause organ inflammations such as myocarditis, pneumonia and encephalitis. Innate …

[HTML][HTML] Synaptic proteins associated with cognitive performance and neuropathology in older humans revealed by multiplexed fractionated proteomics

BC Carlyle, SE Kandigian, J Kreuzer, S Das… - Neurobiology of …, 2021 - Elsevier
Alzheimer's disease (AD) is defined by the presence of abundant amyloid-β (Aβ) and tau
neuropathology. While this neuropathology is necessary for AD diagnosis, it is not sufficient …

Ginsenoside compound K regulates amyloid β via the Nrf2/Keap1 signaling pathway in mice with scopolamine hydrobromide-induced memory impairments

Q Yang, J Lin, H Zhang, Y Liu, M Kan, Z Xiu… - Journal of Molecular …, 2019 - Springer
The objective of this study was to investigate the neuroprotective and antioxidant effects of
ginsenoside compound K (CK) in a model of scopolamine hydrobromide-induced, memory …

Determination of metformin bio-distribution by LC-MS/MS in mice treated with a clinically relevant paradigm

K Chaudhari, J Wang, Y Xu, A Winters, L Wang… - PLoS …, 2020 - journals.plos.org
Metformin, an anti-diabetes drug, has been recently emerging as a potential “anti-aging”
intervention based on its reported beneficial actions against aging in preclinical studies …

TRIM18-Regulated STAT3 Signaling Pathway via PTP1B Promotes Renal Epithelial–Mesenchymal Transition, Inflammation, and Fibrosis in Diabetic Kidney Disease

Q Chen, C Gao, M Wang, X Fei, N Zhao - Frontiers in Physiology, 2021 - frontiersin.org
Diabetic kidney disease (DKD) has become a key cause of end-stage renal disease
worldwide. Inflammation and fibrosis have been shown to play important roles in the …

Association between metformin and Alzheimer's disease: a systematic review and meta-analysis of clinical observational studies

A Luo, P Ning, H Lu, H Huang, Q Shen… - Journal of …, 2022 - content.iospress.com
Background: As one of the widely used drugs for the management of type 2 diabetes
mellites (T2DM), metformin is increasingly believed to delay cognitive deterioration and …

Metformin and cognition from the perspectives of sex, age, and disease

K Chaudhari, CD Reynolds, SH Yang - Geroscience, 2020 - Springer
Metformin is the safest and the most widely prescribed first-line therapy for managing
hyperglycemia due to different underlying causes, primarily type 2 diabetes mellitus. In …

[HTML][HTML] Compounds that extend longevity are protective in neurodegenerative diseases and provide a novel treatment strategy for these devastating disorders

SK Soo, PD Rudich, A Traa, N Harris-Gauthier… - Mechanisms of ageing …, 2020 - Elsevier
While aging is the greatest risk factor for the development of neurodegenerative disease, the
role of aging in these diseases is poorly understood. In the inherited forms of these …